التفاصيل البيبلوغرافية
العنوان: |
Phase I/II study of ipilimumab plus nivolumab (IPI-NIVO) combined with sacituzumab govitecan in patients with metastatic cisplatin-ineligible urothelial carcinoma. |
المؤلفون: |
Jain, Rohit K., Yang, Yuanquan, Chadha, Juskaran, Zhang, Jingsong, Raymond, Sarah, Oschmann, Erika, Poehlman, Trey, Fan, Wenyi, Kim, Youngchul, Dhillon, Jasreman, Chahoud, Jad, Chatwal, Monica Sheila, Sonpavde, Guru P. |
المصدر: |
Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pTPS713-TPS713, 193p |
قاعدة البيانات: |
Supplemental Index |